Bausch & Lomb (TSX:BLCO) Days Payable : 101.51 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Days Payable?

Bausch & Lomb's average Accounts Payable for the three months ended in Mar. 2024 was C$638 Mil. Bausch & Lomb's Cost of Goods Sold for the three months ended in Mar. 2024 was C$574 Mil. Hence, Bausch & Lomb's Days Payable for the three months ended in Mar. 2024 was 101.51.

The historical rank and industry rank for Bausch & Lomb's Days Payable or its related term are showing as below:

TSX:BLCO' s Days Payable Range Over the Past 10 Years
Min: 51.89 Med: 71.51 Max: 99.66
Current: 88.62

During the past 6 years, Bausch & Lomb's highest Days Payable was 99.66. The lowest was 51.89. And the median was 71.51.

TSX:BLCO's Days Payable is ranked better than
58.91% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 73.355 vs TSX:BLCO: 88.62

Bausch & Lomb's Days Payable increased from Mar. 2023 (92.76) to Mar. 2024 (101.51). It may suggest that Bausch & Lomb delayed paying its suppliers.

Bausch & Lomb Days Payable Historical Data

The historical data trend for Bausch & Lomb's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Days Payable Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

72.06

63.54

51.89

71.51

99.66

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial												92.76	81.91	82.14	88.00	101.51

Competitive Comparison of Bausch & Lomb's Days Payable

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's Days Payable Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's Days Payable distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's Days Payable falls into.

Bausch & Lomb Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Bausch & Lomb's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (502.645	+	700.315)	/	2 )	/	2202.908	*	365
=	601.48					/	2202.908	*	365
=	99.66

Bausch & Lomb's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (700.315	+	576.634)	/	2 )	/	573.926	*	365 / 4
=	638.4745					/	573.926	*	365 / 4
=	101.51

Bausch & Lomb Days Payable Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives